Chang-Tao Jiang
Overview
Explore the profile of Chang-Tao Jiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luo W, Zhang Z, Zhang W, Su J, Gao X, Liu X, et al.
Front Endocrinol (Lausanne)
. 2022 Jul;
13:883845.
PMID: 35846275
Objective: This study aimed to explore the relationship between homocysteine (Hcy) and diabetic retinopathy (DR) and the impacts of the Hcy pathway on this relationship against this background. Methods: This...
2.
Wang Y, Jiang C, Song J, Song Q, Ma J, Wang H
Biomed Res Int
. 2020 Jan;
2019:1382418.
PMID: 31915678
Objective: The human lipidomic profile reflects lipid metabolism, including the early phase of pathophysiological changes associated with diseases. An investigation of the association between the plasma lipidomic profile and adolescent...
3.
Lu S, Dang G, Deng J, Liu H, Liu B, Yang J, et al.
Acta Pharmacol Sin
. 2019 Oct;
41(1):47-55.
PMID: 31607752
T cell metabolic activation plays a crucial role in inflammation of atherosclerosis. Shikonin (SKN), a natural naphthoquinone with anti-inflammatory activity, has shown to exert cardioprotective effects, but the effect of...
4.
Li J, Cao Y, Sun X, Han L, Li S, Gu W, et al.
J Diabetes Investig
. 2018 Jul;
10(2):491-498.
PMID: 29999591
Aims/introduction: Metabolomic markers have the potential to improve the predicting accuracy of existing risk scores for type 2 diabetes mellitus. The present study aimed to test the associations between plasma...
5.
Sun L, Jiang C, Wang X
Sheng Li Ke Xue Jin Zhan
. 2018 Jun;
47(5):346-50.
PMID: 29893538
No abstract available.
6.
Dong Y, Zhang X, Sun L, Zhang S, Liu B, Liu H, et al.
Acta Pharmacol Sin
. 2017 Sep;
38(12):1601-1610.
PMID: 28933423
Hyperhomocysteinemia (HHcy) is a key risk factor in hepatic steatosis. In this study, we applied a metabolomic approach to investigate the changes in the metabolite profile due to HHcy-induced hepatic...
7.
Fang Z, Tanaka N, Lu D, Jiang C, Zhang W, Zhang C, et al.
Arch Toxicol
. 2016 Nov;
91(5):2235-2244.
PMID: 27853831
Alpha-naphthyl isothiocyanate (ANIT)-induced liver damage is regarded as a useful model to study drug-induced cholestatic hepatitis. Ultra-performance liquid chromatography coupled with electrospray ionization quadrupole mass spectrometry (UPLC-ESI-QTOF MS)-based metabolomics revealed...
8.
Bi H, Pan Y, Qiu J, Krausz K, Li F, Johnson C, et al.
Carcinogenesis
. 2014 Aug;
35(10):2264-72.
PMID: 25115443
The cell metabolome comprises abundant information that may be predictive of cell functions in response to epigenetic or genetic changes at different stages of cell proliferation and metastasis. An unbiased...
9.
Quan Y, Jiang C, Xue B, Zhu S, Wang X
Acta Pharmacol Sin
. 2011 Feb;
32(2):188-93.
PMID: 21293471
Aim: To investigate whether high glucose stimulates the expression of inflammatory cytokines and the possible mechanisms involved. Methods: ELISA and real-time PCR were used to determine the expression of the...
10.
Kong X, Jiang C, Li Y
Sheng Li Ke Xue Jin Zhan
. 2007 Sep;
38(3):255-7.
PMID: 17882987
No abstract available.